InPoint Commercial Real Estate Stock Price, News & Analysis
Company Description
InPoint Commercial Real Estate (NYSE: ICR-PA) is a publicly traded reit—mortgage company in the Real Estate sector.
On a trailing twelve-month basis, InPoint Commercial Real Estate reported revenue of $23.0M with net income of -$1.6M and diluted earnings per share of $-0.75. The company operates at a net profit margin of -6.8%.
This page provides a comprehensive overview of ICR-PA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ICR-PA Rankings
Latest News
InPoint Commercial Real Estate has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include dividends. View all ICR-PA news →
SEC Filings
InPoint Commercial Real Estate has filed 2 recent SEC filings, including 1 Form 8-K, 1 Form ARS. The most recent filing was submitted on April 15, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ICR-PA SEC filings →
Financial Highlights
InPoint Commercial Real Estate generated $23.0M in revenue over the trailing twelve months, and net income was -$1.6M, reflecting a -6.8% net profit margin. Diluted earnings per share stood at $-0.75. The company generated $11.4M in operating cash flow.
Upcoming Events
Short Interest History
Days to Cover History
ICR-PA Company Profile & Sector Positioning
InPoint Commercial Real Estate (ICR-PA) operates in the REIT—Mortgage industry within the broader Real Estate sector.
Investors comparing ICR-PA often look at related companies in the same sector, including Broadmark Realty Capital Inc (BRMK), EUDA Health Holdings Ltd (EUDAW), Landsea Homes Corp (LSEAW), Murano Global Investments Plc (MRNOW), and National Healthcare Properties Inc (NHPAP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ICR-PA's relative position within its industry.